Literature DB >> 29550678

Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity.

Ying Feng1, Xikui Sun2, Xianmiao Ye3, Yupeng Feng3, Jinlin Wang3, Xuehua Zheng3, Xinglong Liu3, Changhua Yi3, Mingli Hao4, Qian Wang3, Feng Li5, Wei Xu5, Liang Li6, Chufang Li6, Rong Zhou6, Ling Chen7, Liqiang Feng8.   

Abstract

Re-emerging human adenoviruses type 14 (HAdV14) and 55 (HAdV55) represent two highly virulent adenoviruses. The neutralizing antibody (nAb) responses elicited by infection or immunization remain largely unknown. Herein, we generated hexon-chimeric HAdV14 viruses harboring each single or entire hexon hyper-variable-regions (HVR) from HAdV55, and determined the neutralizing epitopes of human and mouse nAbs. In human sera, hexon-targeting nAbs are type-specific and mainly recognize HVR2, 5, and 7. Fiber-targeting nAbs are only detectable in sera cross-neutralizing HAdV14 and HAdV55 and contribute substantially to cross-neutralization. Penton-binding antibodies, however, show no significant neutralizing activities. In mice immunized with HAdV14 or HAdV55, a single immunization mainly elicited hexon-specific nAbs, which recognized HAdV14 HVR1, 2, and 7 and HAdV55 HVR1 and 2, respectively. After a booster immunization, cross-neutralizing fiber-specific nAbs became detectable. These results indicated that hexon elicits type-specific nAbs whereas fiber induces cross-neutralizing nAbs to HAdV14 and HAdV55, which are of significance in vaccine development.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epitopes; Human adenovirus type 14; Human adenovirus type 55; Neutralizing antibodies; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 29550678     DOI: 10.1016/j.virol.2018.03.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Human Desmoglein-2 and Human CD46 Mediate Human Adenovirus Type 55 Infection, but Human Desmoglein-2 Plays the Major Roles.

Authors:  Ying Feng; Changhua Yi; Xinglong Liu; Linbing Qu; Wan Su; Tao Shu; Xuehua Zheng; Xianmiao Ye; Jia Luo; Mingli Hao; Xikui Sun; Liang Li; Xiaolin Liu; Chenchen Yang; Suhua Guan; Ling Chen; Liqiang Feng
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".

Authors:  Yuqian Yan; Shuping Jing; Liqiang Feng; Jing Zhang; Zhiwei Zeng; Min Li; Shan Zhao; Junxian Ou; Wendong Lan; Wenyi Guan; Xiaowei Wu; Jianguo Wu; Donald Seto; Qiwei Zhang
Journal:  Virol Sin       Date:  2020-05-26       Impact factor: 4.327

3.  Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.

Authors:  Xingui Tian; Ye Fan; Changbing Wang; Zhenwei Liu; Wenkuan Liu; Yun Xu; Chuncong Mo; Aiping You; Xiao Li; Xia Rong; Rong Zhou
Journal:  Virol Sin       Date:  2020-11-09       Impact factor: 4.327

4.  Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018.

Authors:  Jae-Hoon Ko; Hyeong-Taek Woo; Hong Sang Oh; Song Mi Moon; Joon Young Choi; Jeong Uk Lim; Donghoon Kim; Junsu Byun; Soon-Hwan Kwon; Daeyoun Kang; Jung Yeon Heo; Kyong Ran Peck
Journal:  Korean J Intern Med       Date:  2019-09-05       Impact factor: 2.884

5.  Genomic Analyses of Potential Novel Recombinant Human Adenovirus C in Brazil.

Authors:  Roozbeh Tahmasebi; Antonio Charlys da Costa; Kaelan Tardy; Rory J Tinker; Flavio Augusto de Padua Milagres; Rafael Brustulin; Maria da Aparecida Rodrigues Teles; Rogério Togisaki das Chagas; Cassia Vitória de Deus Alves Soares; Aripuana Sakurada Aranha Watanabe; Cecilia Salete Alencar; Fabiola Villanova; Xutao Deng; Eric Delwart; Adriana Luchs; Élcio Leal; Ester Cerdeira Sabino
Journal:  Viruses       Date:  2020-05-04       Impact factor: 5.048

6.  A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7.

Authors:  Rong Wang; Jiansheng Lu; Quan Zhou; Lei Chen; Ying Huang; Yunzhou Yu; Zhixin Yang
Journal:  Front Cell Infect Microbiol       Date:  2019-12-04       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.